Crispr Therapeutics: Why I've Become Even More Bullish (Rating Upgrade)

Readers may recall my last article from October 2024 – a deep dive into CRISPR Therapeutics AG (NASDAQ: CRSP ) – in which I outlined several catalysts for the company and its stock going forward. Giving it a buyI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the key to creating wea ...